Industry report addresses OzemPatches ingredient disclosures, transdermal delivery claims, and what ad-exposed consumers ...

A free community event from UnityPoint Health will help people learn more about surgical weight loss options. The “Bariatric ...

The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.

On average, Mochi Health members lose 36 pounds in their first year, and most sustain their weight loss much longer than they ...

In a move that could reshape how obesity and metabolic disease are treated nationwide, federal health officials unveiled a ...

Imagine your body as a complex orchestra with insulin as the conductor that keeps every section in harmony. In diabetes, it ...

Novo Nordisk's Wegovy pill is the first oral GLP-1 receptor agonist approved for weight management, offering a new treatment ...

Access to GLP-1 weight loss drugs could improve the long-term health and well-being for millions of Americans.

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

The FDA has approved Novo Nordisk’s Wegovy pill to reduce excess body weight, support weight management, and maintain weight ...

New evidence shows that remission in type 2 diabetes is attainable through weight loss, surgery, pharmacotherapy, and ...

“The Surgical Quality Partner designation lets patients know IRMC is dedicated to quality and relentless self-improvement and ...